verve-102
·Code: VERVE-102
verve-102: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Verve Therapeutics, Inc. (VERV) | Phase 1 |
Clinical Trials (1)
Open-label, Phase 1b, Single Ascending Dose Study to Evaluate the Safety of VERVE-102 Administered to Patients With Heterozygous Familial Hypercholesterolemia or Premature Coronary Artery Disease Who Require Additional Lowering of Low-density Lipoprotein Cholesterol
Frequently asked questions
Who is developing verve-102?
verve-102 is being developed by Verve Therapeutics, Inc..
How many clinical trials involve verve-102?
BioSniper tracks 1 clinical trial involving verve-102.
Get deeper analysis on verve-102
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis